Results

What launch success looks like.

Selected engagements with the numbers up front. Cases are anonymized; the work and the results are real.

Case study 01 · Strategy · Capabilities

A new class of biologics, six assets, outperforming expectations.

$2.2B → $3.0B

A top 20 global biopharma, a five-year portfolio plan, and an outcome 36 percent above pre-launch consensus.

Read the case →
Case study 02 · Insights · Execution

Stress-testing strategy and pulling it through to local markets.

35% → 95%

A global launch into a hyper-competitive therapeutic area, rehearsed until the organization was ready to win it.

Read the case →

Launch with Precision. Thrive by Design.

If your organization is launching a new therapy where failure is not an option, let's talk.

Contact us